Clinical Trial Data on Acupoint Stimulation and Postoperative Nausea After Hepatectomy

159 patient records from a multicenter double-blinded randomized controlled trial conducted across three tertiary hospitals in China. The study evaluated whether transcutaneous electrical acupoint stimulation (TEAS) added to antiemetic therapy reduces postoperative nausea and vomiting (PONV) within 24 hours after hepatectomy. The dataset was authored by Shan He and last updated on 2026-04-20.

Use Cases

• Analyze the efficacy of TEAS on PONV incidence based on the primary outcome measure described in the trial.
• Investigate the relationship between TEAS and postoperative analgesic use based on patient-controlled analgesia (PCA) attempt and delivery data.
• Compare recovery outcomes like time to ambulation and gastrointestinal function recovery between intervention and control groups.
• Perform meta-analysis on non-pharmacological interventions for PONV by combining this trial's structured results with other studies.

Strengths

• Data originates from a multicenter, double-blinded randomized controlled trial, a high-quality study design.
• Includes results for 159 completed patient cases from the original 161 randomized.
• Reports specific outcome metrics including PONV incidence (23.8% vs 26.6%) and PCA attempts (2.7 vs 3.5).

Limitations

• Row count and column-level documentation are absent; field semantics must be inferred after download.
• The dataset is very small at 53.4 KB, indicating limited scope, likely containing summary results rather than raw patient-level data.
• Data may reflect geographic bias inherent to its collection from three hospitals in China.

Provenance

Source

figshare, authored by Shan He.

Collection Method

Data was generated from a clinical trial (NCT05396716) comparing TEAS to a control during elective hepatectomy.

Freshness

Last updated 2026-04-20 10:18:36; freshness should be verified.

Geography

Three tertiary hospitals in China.